ID

22968

Beschreibung

Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00518882

Link

https://clinicaltrials.gov/show/NCT00518882

Stichworte

  1. 19.06.17 19.06.17 -
Hochgeladen am

19. Juni 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Diabetes NCT00518882

Eligibility Diabetes NCT00518882

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00518882
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes
Beschreibung

ID.1

Datentyp

boolean

Alias
UMLS CUI [1]
C0011860
stable treatment with oral anti-diabetic drugs (metformin, sulphonylurea or a combination of both) for at least 3 months at the discretion of the investigator
Beschreibung

ID.2

Datentyp

boolean

Alias
UMLS CUI [1]
C0935929
hba1c equal to or greater than 7.0% and equal to or lower than 11.0%
Beschreibung

ID.3

Datentyp

boolean

Alias
UMLS CUI [1]
C0019018
body mass index (bmi) equal to or lower than 45.0 kg/m2
Beschreibung

ID.4

Datentyp

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous treatment with insulin
Beschreibung

ID.5

Datentyp

boolean

Alias
UMLS CUI [1]
C0557978
treatment with any anti-diabetic drug other than metformin and sulphonylurea
Beschreibung

ID.6

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C0025598
UMLS CUI [1,3]
C0038766
any previous exposure to exenatide or liraglutide
Beschreibung

ID.7

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0167117
UMLS CUI [1,2]
C1456408
impaired liver or/and renal function
Beschreibung

ID.8

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0232741
UMLS CUI [1,2]
C0232804
history of any significant cardiac events
Beschreibung

ID.9

Datentyp

boolean

Alias
UMLS CUI [1]
C0741923
known retinopathy or maculopathy requiring acute treatment
Beschreibung

ID.10

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0035309
UMLS CUI [1,2]
C0339471
recurrent major hypoglycaemia or hypoglycaemic unawareness
Beschreibung

ID.11

Datentyp

boolean

Alias
UMLS CUI [1]
C0150254

Ähnliche Modelle

Eligibility Diabetes NCT00518882

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00518882
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
ID.2
Item
stable treatment with oral anti-diabetic drugs (metformin, sulphonylurea or a combination of both) for at least 3 months at the discretion of the investigator
boolean
C0935929 (UMLS CUI [1])
ID.3
Item
hba1c equal to or greater than 7.0% and equal to or lower than 11.0%
boolean
C0019018 (UMLS CUI [1])
ID.4
Item
body mass index (bmi) equal to or lower than 45.0 kg/m2
boolean
C1305855 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ID.5
Item
previous treatment with insulin
boolean
C0557978 (UMLS CUI [1])
ID.6
Item
treatment with any anti-diabetic drug other than metformin and sulphonylurea
boolean
C0935929 (UMLS CUI [1,1])
C0025598 (UMLS CUI [1,2])
C0038766 (UMLS CUI [1,3])
ID.7
Item
any previous exposure to exenatide or liraglutide
boolean
C0167117 (UMLS CUI [1,1])
C1456408 (UMLS CUI [1,2])
ID.8
Item
impaired liver or/and renal function
boolean
C0232741 (UMLS CUI [1,1])
C0232804 (UMLS CUI [1,2])
ID.9
Item
history of any significant cardiac events
boolean
C0741923 (UMLS CUI [1])
ID.10
Item
known retinopathy or maculopathy requiring acute treatment
boolean
C0035309 (UMLS CUI [1,1])
C0339471 (UMLS CUI [1,2])
ID.11
Item
recurrent major hypoglycaemia or hypoglycaemic unawareness
boolean
C0150254 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video